Design, Development, and Optimization of Polymeric Based-Colonic Drug Delivery System of Naproxen
Figure 5
Comparison of in vitro release profiles of naproxen sodium core tablets (NF1), press-coated Eudragit RSPO : RLPO formulation (NF6), and press-coated Eudragit RSPO : RLPO tablets enteric coated with Eudragit S-100 in different concentrations of 2.5%, 5.0%, and 7.5% (NF7, NF8, and NF9), respectively. Data are expressed as mean ± S.D. ().
